医学上重要的蛇的汇编,毒液活动和临床表现在加纳
Justus Precious Deikumah1, Robert Peter Biney2, John Koku Awoonor-Williams3
1Department of Conservation Biology and Entomology, School of Biological Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, Cape Coast, Ghana.
加纳的蛇咬毒害报告不足,导致严重的残疾和死亡率. 这项研究详细介绍了蛇毒类型及其分布,有助于诊断和管理蛇咬伤.
科学领域:
- 热带医学 热带医学
- 毒理学 毒理学 毒理学
- 类学 类学 类学
背景情况:
- 毒蛇咬伤 (SBE) 是一种被忽视的热带疾病,具有重大的社会经济影响.
- 在加纳的医疗机构记录中,SBE的记录不足,尽管它会导致残疾和死亡.
- 这项研究解决了对加纳SBE的详细信息的需求.
研究的目的:
- 详细介绍了加纳蛇的分布,习惯和息地.
- 描述毒毒类型及其相关的临床表现.
- 通过了解蛇毒特性,为SBE管理和诊断提供信息.
主要方法:
- 对同行评审的文献,书籍和报告进行结构化的专题桌面审查.
- 在PubMed,WHO,WCH临床毒理学资源和谷歌学者进行的搜索.
- 包括来自加纳卫生服务区卫生信息管理系统的数据.
主要成果:
- 蛇咬被按毒素活动分类:神经毒性,心脏毒性,出血性,细胞毒性,肌毒性,毒性和凝血剂.
- 神经毒性咬伤主要来自类动物;心脏毒性,出血性,毒性和凝血性毒素主要来自Viperidae.
- 在加纳,肌毒性毒素很少见;细胞毒性毒素在Viperidae中很常见;神经毒性和出血性毒素普遍存在.
结论:
- 了解蛇和毒液的特征对于有效的SBE管理至关重要.
- 在农业生态区绘制毒素分布图,有助于物种识别和SBE诊断.
- 这项研究为改善加纳SBE控制提供了必要的数据.
更多相关视频
05:27Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
Published on: October 6, 2023
11:28Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose Herpestes Auropunctatus Sera for Use as an Oral Rabies Vaccination Biological Marker
Published on: May 31, 2019
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Physical Properties of Amines
Prevention of Further Absorption of Poison
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
